Housing developer donates to help establish Frome cancer treatment centre

A housing developer in the South West has donated a significant sum to aid the establishment of a new cancer treatment centre in Frome.
Barratt Homes Bristol gave £1,500 to the Bath Cancer Unit Support Group (BCUSG) to support their project for a cancer treatment outreach facility.
The planned facility, to be located within Frome Medical Centre, will provide systemic anti-cancer treatment, such as chemotherapy - reducing the need for patients to travel to Bath.
BCUSG is a volunteer-run charity, and works closely with medical professionals at the Royal United Hospital in Bath.
Alan Webb, fundraising lead and trustee at BCUSG, said: "We are incredibly grateful for Barratt Bristol's generous donation, which will go directly towards the final phase of funding for the new Frome treatment hub."
Andrea Pilgrim, sales director for Barratt Homes Bristol, said: "We are delighted to support such a brilliant charity that makes a tangible difference to cancer patients and their families across the region."
The charity, founded in the mid-1980s, has raised more than £6m to fund necessary equipment and facilities for cancer treatment in Bath and the surrounding areas.
A team of 13 trustees and more than 100 volunteers ensure that around 95 per cent of the money raised goes directly to their projects.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Bloomberg

2 hours ago

• Bloomberg

Health Insurers Pledge to Reduce Red Tape for Care Approval

A group of the nation's largest health insurers agreed to streamline preapprovals for medical care, addressing a controversial process that can result in delays or outright denials of patient treatment. The insurers pledged to reduce the number of procedures that require so-called 'prior authorization,' standardize processes across different plans and ensure 80% of electronic approvals for medical claims are answered in real time. The voluntary changes, which would be implemented on varying timelines by 2027, are set to be formally announced on Monday.

Yahoo

2 hours ago

• Yahoo

Oscar Health (OSCR) Skyrockets 52% W/W. Time to Take Profits?

Oscar Health, Inc. (NYSE:OSCR) is one of the . Oscar Health jumped by 52 percent week-on-week, finishing at $21.22 versus the $13.95 on June 13, with analysts naming it a meme stock amid the lack of clear catalysts to boost buying appetite. Last week's shortened trading saw Oscar Health, Inc. (NYSE:OSCR) trade higher for four consecutive days, reflecting strong investor confidence amid macroeconomic uncertainties. Additionally, sentiment may have been supported by a new proposal for the Medicare Advantage, called 'Part E,' that would allow individuals and employers to enroll voluntarily. While this would heighten competition with private insurers, the voluntary enrollment could potentially delay or prevent Medicare's sooner-than-expected insolvency, and indirectly benefit Oscar Health, Inc. (NYSE:OSCR) and other private insurers. A close up of a patient and a healthcare professional engaging in conversation, showing the company's commitment to patient care. While we acknowledge the potential of OSCR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Wall Street Journal

2 hours ago

• Wall Street Journal

Republican's Life-Threatening Pregnancy Collided With Florida's Abortion Politics

Rep. Kat Cammack arrived at the emergency room in May 2024 terrified by what she had just learned: Her pregnancy could kill her at any moment. It would only get worse. The Florida Republican needed a shot of methotrexate to help expel her ectopic pregnancy, in which there is no way for the embryo to survive. Her state's six-week abortion ban had just taken effect. She said doctors and nurses who saw her said they were worried about losing their licenses or going to jail if they gave her drugs to end her pregnancy.